Latest / "Isn't That Interesting?!": Breast Cancer Survivor Stories + Remarkable Research / Season 3 / Episode 6: Dr. Orit Uziel
Transcript
- 0:00With every donation you make to earlier.org, another researcher
- 0:04gets the chance to test a new theory.
- 0:06Sometimes these grants lead to incredible breakthroughs.
- 0:10Other times there are setbacks. But either way, every
- 0:14opportunity brings US one step closer to what could lead to an
- 0:18earlier detection of breast cancer.
- 0:20Here's Martha Kaley, founder and executive directorofearlier.org,
- 0:25with this week's episode of Isn't That Interesting?
- 0:28Welcome to isn't that interesting and we have a
- 0:32wonderful researcher here from Israel and is Doctor Orit Ezell
- 0:38is that correct? OK, very good.
- 0:42And I am so excited for her to discuss what our grant, we gave
- 0:47her a grant in 2016 and she didn't get the results that she
- 0:53was expecting. And so we're going to discuss
- 0:57that. I think that's a beautiful
- 0:59example of why we actually fund these kind of grants, because
- 1:04you never know how they're going to show up, but a failure is
- 1:08still a positive because you know what not to do.
- 1:11So you could just go ahead and talk about, share some of your
- 1:16experience and research. OK.
- 1:18Thank you very much for this initiative and thank you for the
- 1:22funding that you gave me at 10 years ago.
- 1:25Yeah, it was very helpful. OK.
- 1:27The idea was to concentrate on a positive way or a different way
- 1:33to identify or to diagnose a a breast cancer and other cancers
- 1:38as well. And as you may know, I mean, the
- 1:41new thinking now the last couple of years is using liquid
- 1:46biopsies, meaning that you don't have to, you know, to take the
- 1:50real biopsy from the breast or whatever organ, but to take a
- 1:54blood sample and diagnosed whatever you want to do in this
- 1:59blood sample. So don't be too penetrative and,
- 2:03and don't hurt anybody and so on.
- 2:06So we concentrated on small vesicles named the exosomes.
- 2:11Exosomes are really like, you know, a fiction like like
- 2:16science fiction, meaning that in, in, in terms that they're
- 2:20very tiny vesicles that are secreted from actually every
- 2:25cell in our body and all over plants also secrete exosomes,
- 2:30bacteria, you name it, and they are secreted out of the cells.
- 2:35So you can find them actually everywhere in the ocean, in
- 2:39breast milk, in the beer, and of course in the blood and urine
- 2:44and lymph node and so on. So these exosomes contain
- 2:49actually like a mirror of the molecular profile of the cell
- 2:54that sends them out. So the idea is that if a cancer
- 2:58cell, for example breast cancer cell send exosomes to the
- 3:02bloodstream, it should contain the molecular profile of its own
- 3:08of the mother cell. And if the this cancer, this
- 3:13cell is a cancer one, it should contain the cancer markers.
- 3:17And we concentrate on telomerase.
- 3:20Telomerase is an enzyme that typifies cancer cells because
- 3:26actually it maintains telomerase.
- 3:29Telomerase are the end part of every exosome, every chromosome
- 3:35that we have. In normal conditions, these
- 3:39telomeres are getting shorter in every cell division until they
- 3:44come to a certain length which signals the cell to stop,
- 3:48divide, sinness and die. And this is a beautiful natural
- 3:53state. However, in cancer cell you have
- 3:57telomerase, an enzyme that prevents telomere shortening.
- 4:01And in this way it provides the cell with eternity, it provides
- 4:06the cell for a limitless life expectancy.
- 4:11So telomerase actually typifies cancer cells only cancer cells,
- 4:16all, all kinds of cancer cells. So we and we investigated
- 4:21telomerase and telomeres, you know, like 2 decades before.
- 4:26So we thought, OK, let's see if the, the RNA part of, you know,
- 4:33that there is a DNA and then it translates to RNA and then
- 4:38transcribes to a protein. So the idea was let's look for
- 4:43the RNA that belongs to telomerase and look it look for
- 4:48it in the bloodstream to use it as a diagnostic marker.
- 4:53Now we we understand very quickly that if we want to find
- 4:57an RNA molecule in the bloodstream, they should be
- 5:00protected in these tiny vesicles in exosomes.
- 5:04So we said, OK, let's say isolate exosomes and try to
- 5:09locate to find the RNA part of telomerase in them.
- 5:15This was the idea. And so in the initial study we
- 5:21took a blood samples from many types of cancer patients, both
- 5:26solids and malignant and the hematological ones and we found
- 5:31and we looked for the expression of telomerase RNA in their
- 5:35exosomes. So we are talking about liquid
- 5:38biopsy because we took, you know, you took a few milliliters
- 5:43of blood, isolate the exosomes very, you know, in a very easy
- 5:48way and then analyze their RNA to look for this telomerase
- 5:53unit. So all over we found that about
- 5:572/3 of all types of cancers and the half of all the
- 6:02hematological cancers do contain the RNA unit of telomeras in
- 6:09their exosomes. And then we decided, you know,
- 6:11to concentrate on uncertain diseases because we were able to
- 6:17follow a certain types of diseases in this in this regard.
- 6:22And one of the types was breast cancer.
- 6:25So that's why we, you know, we sent this say grant to you and
- 6:29you were so nicely A generous, generous to to give us the
- 6:34money. But unfortunately, when we
- 6:37analyzed it, we didn't find a real correlation between the
- 6:40disease state and the level of telomeras in their exosomes.
- 6:46So this was disappointing. But but, and, and we try, you
- 6:51know, we try to do it in other diseases as well.
- 6:54And we did find for example in gastric cancer, we did find
- 6:59correlation between a disease state aggressiveness and the
- 7:03level of telomeras in the exosomes.
- 7:06And in lung cancer also we also find correlation.
- 7:11And in brain tumors we found that you know, in GBM
- 7:15glioblastoma multiforma, which is the most aggressive type
- 7:21again, the exosomes that were travel in the in the blood, you
- 7:25know not in the brain, in the blood of these patients did
- 7:28contain high levels of telomeras in their exosomes.
- 7:34Let me ask you, what do you, what is your thinking of why it
- 7:40didn't demonstrate in breast cancer?
- 7:43OK. So I can tell you that, you
- 7:46know, tumors are very heterogeneous and so on.
- 7:51And the tumor cells, I mean their dependency on telomeras,
- 7:57it varies is very different because as I told you, telomeras
- 8:01confers limitless, limitless lifespan to cells, mainly to
- 8:05cancer cells. However, I mean the the body is
- 8:09smart enough to find other mechanisms as well.
- 8:14For example, it is, I mean the cells are smart enough to take
- 8:18telomeres and by homologous through combination they can
- 8:23maintain telomers to the right length.
- 8:26For example, if a short telomere is having a a loan, a loan from
- 8:35the long telomere from another chromosome in which the telomer
- 8:39is long, then you know they they can maintain the telomere
- 8:42lengths and dependently without connection to telomeras.
- 8:47So probably this is the mechanism and it is called the
- 8:51alternative lengthening of telomeras.
- 8:55OK. All right.
- 8:56So probably this was the yeah, this was the reason.
- 9:00OK. So then you into the hematology
- 9:04with it, correct? Right, Yes, we moved to
- 9:07hematology, although you know when you think about it, if it
- 9:10is hematology, so you may say why do you need liquid biopsies?
- 9:15I mean, if it's leukemia, you have the cancer cells in the
- 9:18blood, but in terms of I mean in the case of lymphomas you, you
- 9:23don't have it. So then you have you know the
- 9:27initiative. I mean there is a rational to do
- 9:30this research. I can tell you about several
- 9:34studies of ours which were really interesting until in
- 9:38terms of the role of these exosomes in the biology of the
- 9:44cancer in in in general. Then I can tell you about other
- 9:49markers that I think we can look for in breast cancer.
- 9:54Well, tell me about that. Go ahead, tell me.
- 9:57Tell me all. Tell me how it can.
- 9:58OK. So I'll start with the OK.
- 10:01There is a disease called the CLL, chronic lymphatic leukemia
- 10:06and this no, this disease, I mean the no plastic cells, it is
- 10:10known that their survival is dependent on their micro
- 10:15environment. I mean it is known that they are
- 10:18getting help, they're getting support from other cells in the
- 10:23bloodstream, in the circulation that they meet during their
- 10:27travelling. But it wasn't exactly known, I
- 10:31mean fully known how this is this works.
- 10:34So what we showed is the following.
- 10:36The adenoplastic cells send exosomes, which can be taken up
- 10:42by endothelial cells. I didn't tell you about this
- 10:46part. I mean, when cells send
- 10:48exosomes, this exosomes can travel in the bloodstream, for
- 10:52example, in the human body and then they can be taken up by
- 10:56recipient cells. So in our study, we asked, OK,
- 11:01if these exosomes from CLL cells taken up by endotelial cells,
- 11:07what, what is their role in these cells?
- 11:09Why they are taking, I mean, why do they do it?
- 11:12Why teleologically can it's not. But when they're engulfed by
- 11:17these endotelial cells, what's going on?
- 11:20So the idea in in general, not in our system, or only that when
- 11:26exosomes are engulfed in the recipient cells, they pour, they
- 11:31pour all their molecular content in the recipient cells.
- 11:36And since some of these molecules are biologically
- 11:39active, they can manipulate the recipient cells.
- 11:44I'm telling you, it's a science fiction.
- 11:46They can manipulate the recipient cell to change its
- 11:50features to their benefit, like, you know, and therefore,
- 11:54therefore exosomes are regarded as a cell to cell communicators,
- 12:00a way to communicate between cells.
- 12:03I'll just sell, you know, in brackets.
- 12:05For example, I have a colleague in Israel in the Weitzman
- 12:08Institute. She studies the exosome of
- 12:12malaria, Malaria, the parasite and she showed that these
- 12:16parasites, you know, they sent their exosomes to our
- 12:19bloodstream and attacked red blood cells, preparing them to,
- 12:26to the new parasites to be attacked.
- 12:28And you know, that's how the disease is, is spread.
- 12:31It's, it's amazing. It's amazing.
- 12:34And then another study of colleagues of ours in our
- 12:38building in the in Wellington, he's a neurologist and he showed
- 12:43that exosomes are involved in a, in a neurological diseases like
- 12:48Alzheimer or autism or whatever. And they were ever able to show
- 12:55that if you take an autistic mice, autistic mouse for an A
- 13:01mother, for example, if she's autistic, then she doesn't know
- 13:05how to treat her puppies, her offspring.
- 13:09She you know, she ignores them and so on.
- 13:12When she gets exosomes via via a nose drop from healthy stem
- 13:18cells, she behaves completely like a normal mouse.
- 13:23I mean, she starts to treat it's amazing.
- 13:26It's to treat the puppies and be more talkative and more socially
- 13:31involved. So you know, this is only in
- 13:33brackets how exosomes are so fantastic, right.
- 13:37So I have. I think this is so amazing and
- 13:43the, the, the whole essence of it is that now we're looking at
- 13:48not just seeing a tumor, we're looking at the cellular, the
- 13:54whole impact of the cellular cellular concept.
- 13:58And I yeah. And, and also what I find so
- 14:02fascinating is that now we're, we're back, we're even further
- 14:07down the road looking at components of the cells, not and
- 14:12the proteins of the cells. I find it just so enlightening
- 14:17that we're approaching diagnosing and monitoring breast
- 14:23cancer from so many different aspects.
- 14:27We're looking at it with so, so much more information.
- 14:31How, how do you feel like that? There's been an explosion of of
- 14:36findings this and it just seems like I've been watching this for
- 14:4130 years and it just seems like in the last maybe 5 to 10 years,
- 14:46it seems like we have progress are progressing so much more
- 14:50rapidly. How do you see AI with that too?
- 14:54Yeah, yeah. Let me finish first the story
- 14:57about CLL and then breast cancer and then I'll answer you.
- 15:01OK. So what we found is that when a
- 15:04CLL cell sends its its exosomes to the endothelial cells.
- 15:09You know eutelial cells are the cells that are in the blood
- 15:12vessels are in there are engulfed by this endothelial
- 15:16cells and they induce them to secrete cytokines.
- 15:22Cytokines are molecules that support growth, right?
- 15:26For example, I6I6 is a famous cytokine.
- 15:30Now we show that if this cytokine I6 is absorbed in the
- 15:35in a fresh, no plastic serial cell, it blocks apoptosis,
- 15:41blocks apoptosis and actually provides the, the neoplastic
- 15:44cell with the survival advantage.
- 15:47So if you think about I'm, for example, I'm a cancer cell, I'm
- 15:51sending you my exosomes, you're sending me your I6 and then I
- 15:56can flourish and you know, and the, the cancer can be more
- 16:00aggressive. So you know, it's fantastic.
- 16:04So this is about the cancer cell, about cancer in general.
- 16:08You're absolutely right. There are many, I mean, you can,
- 16:12you can define this as explosion of knowledge and many new novel
- 16:17and smart ways to treat cancer. And I'll get back to it in a
- 16:22minute. Now about a breast cancer, I can
- 16:25tell you that we tried to start another study depending on a
- 16:31very interesting study of a colleague of mine in Jerusalem.
- 16:35And they found that when they take the saliva, only the saliva
- 16:41of BRCA, BRCA positive women and compare the content of their
- 16:48exosomes to the normal population, they found that a
- 16:54molecules termed transcripts, alternative splice factors.
- 17:00I'll tell you about it in a minute.
- 17:03They are in a high level comparing to the normal
- 17:07population. So they can serve, I mean, in,
- 17:10in, in potentially they can serve, serve as diagnostic
- 17:14marker to these women. Although they didn't develop
- 17:18cancer yet, You know, they, they only have the mutation, they are
- 17:21only carriers right now these molecules, you know, the in the
- 17:27genome project they found like 100,000 proteins that we have,
- 17:35but only 20,000 genes that encodes for them.
- 17:40How come it appears that every gene can be the template or can
- 17:45code for several proteins and the molecules that are
- 17:51responsible for this, this process are called the
- 17:54alternative splice factors. They manipulate the RNA
- 17:59molecules in various ways. So 1 gene can form, you know,
- 18:05several variations of proteins. So they found this these these
- 18:11markers, this group of genes called alternative splice
- 18:16factors that makes the difference between the exosomes
- 18:21in the saliva of the BRCA positive women and the normal
- 18:25population. So we decided the, you know, we
- 18:29can take it further and the, and the now we have, we conduct a
- 18:34research in the brain, brain cancer tumors and also in
- 18:40hematological malignancies asking whether this molecules in
- 18:45the exosomes can serve as diagnostic markers, right.
- 18:50And yeah, and we, we have any, you know, initial results saying
- 18:54that there are, but, you know, it's very interesting.
- 18:57We thought that there, there are several degrees of course of
- 19:01brain tumors. The most aggressive one is the
- 19:04glioblastoma multiforma GBM, right.
- 19:07And then you have meningiomas and you have low grade glioma.
- 19:11And interestingly enough, the meningioma patients, they had
- 19:17this alternative spice factors levels in their exosomes higher
- 19:21than everybody else. And we analyzed 3 genes and we
- 19:26saw it in, in all, in each one of these three genes.
- 19:30So maybe, you know, maybe this can be a, a marker, not
- 19:34telomerase, but these guys can serve as markers.
- 19:38And indeed the research, I mean one, one level of research in
- 19:43the exosomal field is use it as a marker, find molecules that
- 19:50can be used as a marker and then you have liquid biopsies and you
- 19:53are happy you don't have to go through a real biopsy and so on.
- 19:58So this is indeed one of the of the ways of research in the
- 20:03exosome of, of the path of the path of the research.
- 20:08What else I wanted to tell you so.
- 20:10In terms of, you know, the new methodologies or treatments to
- 20:17to combat cancer. So you have this CAR T thing
- 20:22which is really amazing. And the, so the idea is to take
- 20:27your T cells, manipulate them outside, bring them back and
- 20:32then they, they are, they can be target, they can target the
- 20:36cancer cells and they are self. So they are your, your cells.
- 20:41So they can target the, the tumor.
- 20:43And they, I know personally, we have a friend that was cured of
- 20:47multiple myeloma due due to this treatment.
- 20:51And they in our hospital, they now they develop the, this CAR T
- 20:57technique to treat solid tumors like breast cancer, right?
- 21:03So let's hope, let's hope this will be, you know, promising.
- 21:07And the other thing is immuno immuno checkpoints, a blockade
- 21:13so to, to get rid of the immuno immunology immunological
- 21:19blockade that the cancer cells are smart enough to, to create
- 21:23by the way, they do it via exosomes as well.
- 21:26This process is also mediated by exosomes.
- 21:29So to to you know, to diminish is blockade and then the body
- 21:33will be able to fight cancer immunologically by itself.
- 21:38So this is also very promising way and exosomes also way, I
- 21:44mean, you can think about a way to take out the exosomes of a
- 21:49patient and to manipulate them so they will contain some drug
- 21:54or some suicide gene or whatever, then, you know, bring
- 21:59them back in the body and then they can be like bullets to the
- 22:05against the cancer cells. So yeah, we should be
- 22:09optimistic, you know, we should be, should be.
- 22:12I agree. I just, I love hearing
- 22:15discussing this with the researchers because it just
- 22:19gives such insight to, to how big this can be and, and yet how
- 22:26small it is with the discovery of it.
- 22:29So I, I feel like it is just a real exciting time in our lives
- 22:34to be, to be able to see this. So I would like for you to hurry
- 22:39up and get it all done now so that we can go merrily on our
- 22:42way and not have worry about this anymore.
- 22:46So. Hopefully, yeah, this is the,
- 22:48you know, the the idea is to make cancer and just, you know,
- 22:52a regular, exactly controllable disease that you can live with.
- 22:57And this is the the goal. Yeah.
- 23:00Right. Just a chronic disease and a
- 23:02chronic. This was the word that I missed.
- 23:04A chronic disease. Right, Yeah, I I get it.
- 23:07I, I would love to see that and I think we're, I think we can
- 23:10get there. Don't you feel like you can get
- 23:12there? I really see.
- 23:13I do feel, yeah, you know, I'm optimistic.
- 23:16If I won't be optimistic, I won't talk to you because, you
- 23:18know, people in Israel, some of them are really miserable.
- 23:21They don't know what's going to happen.
- 23:23You know, in half an hour, the ultimatum of Trump is going to I
- 23:29mean, he's going to block the hormones point and and we are
- 23:35going to suffer. I mean the Iranian will be will
- 23:38go angry and we're we are going to go to the shelter again.
- 23:42So if I want to be optimistic, I'll be able to live in this
- 23:45country, so. Well, we're all cheering for you
- 23:49and I just appreciate the fact that we got a chance to do this
- 23:53and I hope that you're able to move on with your research.
- 23:57And I just thank you so much for sharing your information and
- 24:02wish you all the best and and make it fast because we want to
- 24:06get rid of this. So, so thank you so much.
- 24:09I appreciate it. Thank you.
- 24:11Thank you. It was a pleasure for me to talk
- 24:13to you. Really, really.
- 24:15I'll be happy to do it again, OK?
- 24:17Sounds good. OK, When you come up with
- 24:19something else, let me know. I mean I.
- 24:22Will I? Will.
- 24:24I'm promising. OK, I will.
- 24:26OK. OK, take care.
- 24:28Thanks a lot. Thank you.
- 24:30OK. Thank you.
- 24:31This episode of Isn't That Interesting was made possible
- 24:35thanks to volunteers and donors just like you.
- 24:37It was hosted by Martha Kaley, founderofearlier.org and edited
- 24:42by Liam Mcburney. I'm Valerie Amsterdam, reminding
- 24:45you that for the last 30 years, this is North Carolina based
- 24:48organization has helped fund groundbreaking research all over
- 24:52the world from molecular imaging to a sensitive blood test for
- 24:56breast cancer. Plain and simple, earlier
- 24:59detection saves lives. And you can help host a
- 25:02fundraising event, make a donation for volunteer your
- 25:05time. You can find us not only on the
- 25:07web, but on Facebook and Instagram too.
- 25:10Let's change the picture of breast cancer together.